The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke

BACKGROUND: Alteplase is the only approved thrombolytic agent for acute ischaemic stroke. The overall benefit from alteplase is substantial, but some evidence indicates that alteplase also has negative effects on the ischaemic brain. Tenecteplase may be more effective and less harmfull than alteplas...

Descripción completa

Detalles Bibliográficos
Autores principales: Logallo, Nicola, Kvistad, Christopher E, Nacu, Aliona, Naess, Halvor, Waje-Andreassen, Ulrike, Asmuss, Jörg, Aamodt, Anne Hege, Lund, Christian, Kurz, Martin W, Rønning, Ole Morten, Salvesen, Rolf, Idicula, Titto T, Thomassen, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029902/
https://www.ncbi.nlm.nih.gov/pubmed/24886064
http://dx.doi.org/10.1186/1471-2377-14-106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029902/
https://www.ncbi.nlm.nih.gov/pubmed/24886064
http://dx.doi.org/10.1186/1471-2377-14-106

Ejemplares similares